Targeting DNA damage repair genes to overcome cisplatin-resistance in bladder cancer cells and identification of new factors contributing to bladder cancer progression
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Ulm, Universität Ulm, Dissertation, 2023
- Schlagwort
-
Krebs
Blasenkrebs
Blasenkrebs
Chemotherapie
Inhibitor
CRISPR/Cas-Methode
- DOI
-
10.18725/OPARU-51442
- URN
-
urn:nbn:de:bsz:289-oparu-51518-1
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chen, Mingquan
- Universität Ulm
Entstanden
- 2023
Ähnliche Objekte (12)
Targeting HNRNPU to overcome cisplatin resistance in bladder cancer
Bladder cancer
Metastasis of breast cancer to bladder
Treatment of bladder cancer
Percutaneous Ureteral Embolization to Manage Fistulous Bladder Cancer
New treatments in bladder cancer
Molecular markers in bladder cancer
Advances in bladder cancer imaging
Radiotherapy in metastatic bladder cancer
Correction to: New insight for metformin against bladder cancer
Cancer derived exosomes induce macrophages immunosuppressive polarization to promote bladder cancer progression
C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation
Targeting HNRNPU to overcome cisplatin resistance in bladder cancer
Bladder cancer
Metastasis of breast cancer to bladder
Treatment of bladder cancer
Percutaneous Ureteral Embolization to Manage Fistulous Bladder Cancer
New treatments in bladder cancer
Molecular markers in bladder cancer
Advances in bladder cancer imaging
Radiotherapy in metastatic bladder cancer
Correction to: New insight for metformin against bladder cancer
Cancer derived exosomes induce macrophages immunosuppressive polarization to promote bladder cancer progression
C14orf166 is a high-risk biomarker for bladder cancer and promotes bladder cancer cell proliferation
Targeting HNRNPU to overcome cisplatin resistance in bladder cancer
Bladder cancer
Metastasis of breast cancer to bladder
Treatment of bladder cancer
Percutaneous Ureteral Embolization to Manage Fistulous Bladder Cancer
New treatments in bladder cancer
Molecular markers in bladder cancer
Advances in bladder cancer imaging
Radiotherapy in metastatic bladder cancer
Correction to: New insight for metformin against bladder cancer
Cancer derived exosomes induce macrophages immunosuppressive polarization to promote bladder cancer progression